483 Par Pharmaceuticals Feb 2009

483 Par Pharmaceuticals Feb 2009

Uttaniti Limchumroon FDA, Caryn Mcnab FDA, Steven Porter FDA$119.00 - Available Now

FDA investigators audited the Par Pharmaceuticals - Irvine, CA, United States facility and issued inspectional observations (via FDA 483) on 17 Feb 2009.

Product details

  • Category: Human Drugs
  • Inspection end: 17 Feb 2009
  • Location: Irvine, United States
  • FEI: 3004492248
Add To Cart